The global chiral chromatography columns market size is anticipated to reach USD 141.5 million by 2030 and is expected to expand at a CAGR of 4.4% during the forecast period, according to a new report by Grand View Research, Inc. The growing demand for enantiomeric separation in pharmaceutical applications primarily drives the market.

As the development of single-enantiomer drugs becomes increasingly critical for therapeutic efficacy and regulatory compliance, pharmaceutical companies are investing heavily in advanced analytical technologies. Chiral chromatography columns play a pivotal role in ensuring the purity and safety of these compounds, making them indispensable in drug discovery, quality control, and production processes. The rising prevalence of chiral compounds in marketed drugs further amplifies the need for precise and reliable separation techniques.

Technological advancements in column chemistry and stationary phase design contribute significantly to market growth. Innovations such as polysaccharide-based selectors, macrocyclic antibiotics, and protein-based phases have enhanced the resolution and selectivity of chiral separations, enabling faster and more cost-effective analyses. These improvements support pharmaceutical research and extend the application of chiral chromatography to biotechnology, environmental analysis, and food safety testing. Additionally, the increasing adoption of high-performance liquid chromatography (HPLC) systems and pre-packed columns reflects a broader trend toward automation and standardization in laboratory workflows.

Regional dynamics further underscore the market’s momentum. North America continues to lead due to its robust pharmaceutical infrastructure and early adoption of cutting-edge analytical tools. Meanwhile, Asia is emerging as a high-growth region, fueled by expanding generic drug manufacturing and evolving regulatory frameworks in countries such as India and China. Government funding for scientific research and innovation, particularly in Europe and North America, is crucial in sustaining demand for high-performance chiral chromatography.

Order a free sample PDF of the Chiral Chromatography Columns Market Intelligence Study, published by Grand View Research. 

Further key findings from the report suggest:

• Based on type, the High-performance liquid chromatography (HPLC) columns segment held the largest revenue share of 48.6% in 2024.
• Based on product, the pre-packed columns segment led the market and accounted for the largest revenue share of 76.6% in 2024.
• Based on material, the metal based segment dominated the global market and accounted for the largest revenue share of 41.3% in 2024.
• Based on end use, the pharmaceutical & biotechnology segment held the dominant position in the global market with the largest revenue share of 26.4% in 2024.
• North America chiral chromatography columns market dominated the global industry with the largest revenue share of 38.0% in 2024.

List of Key Players in the Chiral Chromatography Columns Market

• Agilent Technologies, Inc.
• Waters Corporation
• Thermo Fisher Scientific, Inc.
• Merck & Co., Inc
• Cytiva
• Danaher
• GE Healthcare
• Shimadzu Corporation
• Daicel Corporation
• Bio-Rad Laboratories
• Perkin Elmer